CGON
CG Oncology, Inc.
67.40$
+0.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -5.9% | +190.6% | -2.6% | -2.1% | +36.6% | -3.5% | -3.7% | +4.1% | +8.5% | +43.4% | -4.4% | |
| – | -7.4% | +198.1% | -2.5% | -2.1% | +36.6% | -7.0% | -4.0% | +3.4% | +9.2% | +45.1% | -4.8% | |
| – | -19.5% | +837.2% | -67.5% | +72.6% | +492.2% | -83.9% | -64.7% | +208.7% | -28.0% | +3.7% | -41.7% | |
| – | -7.9% | +201.9% | -2.4% | -2.2% | +37.2% | -7.2% | -4.0% | +2.9% | +9.1% | +45.0% | -4.5% | |
| – | +9,100.0% | +66.3% | +19.0% | -24.7% | +470.1% | -55.8% | +62.9% | -8.4% | +33.6% | +85.3% | -67.3% | |
| – | – | – | – | – | – | – | – | – | +4.3% | -4.6% | -32.8% | |
| – | – | – | – | – | – | – | – | – | -19.6% | +0.0% | +0.0% | |
| – | – | – | – | – | – | – | – | – | -65.6% | -2.6% | -2.7% | |
| – | +20.7% | -29.9% | +17.7% | +31.2% | +36.4% | +9.4% | +32.7% | +36.0% | -7.8% | +11.5% | +30.0% | |
| – | +21.8% | -30.0% | +18.7% | +31.9% | +36.7% | +6.0% | +34.2% | +0.5% | +1.0% | +14.2% | +34.1% | |
| – | +265.6% | -72.0% | +7.7% | -5.1% | -17.3% | +37.1% | +12.9% | +216.7% | +0.3% | +16.5% | -7.6% | |
| – | +65.3% | +43.7% | -3.6% | -9.2% | +59.9% | +3.3% | +5.9% | +29.0% | -37.8% | +44.1% | +54.5% | |
| – | – | – | – | – | – | – | – | – | +0.0% | +0.0% | +0.0% | |
| – | -7.5% | +207.9% | -2.9% | -2.8% | +36.6% | -3.9% | -4.9% | +2.6% | +9.4% | +45.1% | -5.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.7% | -3.5% | +17.5% | +0.1% | +0.7% | +0.7% | +9.3% | +4.4% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.